An Analysis of Surgical Complications, Morbidity, and Cost Calculation in Patients Undergoing Multimodal Treatment for Operable Oropharyngeal Carcinoma
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
An Analysis of Surgical Complications, Morbidity, and Cost Calculation in Patients Undergoing Multimodal Treatment for Operable Oropharyngeal Carcinoma
Description:
<jats:title>Abstract</jats:title><jats:p><jats:bold>Objective/Hypothesis:</jats:bold> Tumor control and survival are considered the most important measures of treatment efficacy for patients with primary oropharyngeal squamous cell carcinoma. Furthermore, multimodal treatment protocols should be judged by their complication rates, morbidity, and therapy costs.</jats:p><jats:p><jats:bold>Study Design:</jats:bold> The results of a combined approach of primary surgery and neck dissection with postoperative radio)chemo)therapy were analyzed in retrospective chart review.</jats:p><jats:p><jats:bold>Methods:</jats:bold> Two hundred eleven patients' records were analyzed for surgical complications, therapeutic morbidity, and treatment costs.</jats:p><jats:p><jats:bold>Results:</jats:bold> The rate of postoperative hemorrhage was 4.7%. We observed no fatal complications. Ten percent of our patients required nutrition through percutaneous endoscopic gastrostomy (PEG). Twelve percent of all patients required long‐term tracheostomy. The rates of PEG and tracheostomy were significantly higher in patients operated by the transcervical approach. The costs for the combined approach ranged from 10,587 euros ($13,377) to 24,531 euros ($30,996).</jats:p><jats:p><jats:bold>Conclusions:</jats:bold> The presented multimodal approach provides a low rate of surgical complications and a tolerable morbidity. Considering the excellent oncologic results, this extensive and more cost‐intensive multimodal approach is justified for patients with oropharyngeal cancer.</jats:p>